These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 20506394

  • 21. Glucagon-like peptide-1 stimulates type 3 iodothyronine deiodinase expression in a mouse insulinoma cell line.
    Akiyama S, Ogiwara T, Aoki T, Tsunekawa K, Araki O, Murakami M.
    Life Sci; 2014 Oct 12; 115(1-2):22-8. PubMed ID: 25241124
    [Abstract] [Full Text] [Related]

  • 22. Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1.
    Crajoinas RO, Oricchio FT, Pessoa TD, Pacheco BP, Lessa LM, Malnic G, Girardi AC.
    Am J Physiol Renal Physiol; 2011 Aug 12; 301(2):F355-63. PubMed ID: 21593184
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells.
    Schlatter P, Beglinger C, Drewe J, Gutmann H.
    Regul Pept; 2007 Jun 07; 141(1-3):120-8. PubMed ID: 17276524
    [Abstract] [Full Text] [Related]

  • 25. Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart.
    Angelone T, Filice E, Quintieri AM, Imbrogno S, Amodio N, Pasqua T, Pellegrino D, Mulè F, Cerra MC.
    Nutr Metab Cardiovasc Dis; 2012 Jun 07; 22(6):486-94. PubMed ID: 21186112
    [Abstract] [Full Text] [Related]

  • 26. Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin.
    Willard FS, Wootten D, Showalter AD, Savage EE, Ficorilli J, Farb TB, Bokvist K, Alsina-Fernandez J, Furness SG, Christopoulos A, Sexton PM, Sloop KW.
    Mol Pharmacol; 2012 Dec 07; 82(6):1066-73. PubMed ID: 22930710
    [Abstract] [Full Text] [Related]

  • 27. A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists.
    Golla R, Seethala R.
    J Biomol Screen; 2002 Dec 07; 7(6):515-25. PubMed ID: 14599349
    [Abstract] [Full Text] [Related]

  • 28. Enhanced protection against cytokine- and fatty acid-induced apoptosis in pancreatic beta cells by combined treatment with glucagon-like peptide-1 receptor agonists and insulin analogues.
    Tews D, Werner U, Eckel J.
    Horm Metab Res; 2008 Mar 07; 40(3):172-80. PubMed ID: 18348079
    [Abstract] [Full Text] [Related]

  • 29. GLP-1 (9-36) amide metabolite suppression of glucose production in isolated mouse hepatocytes.
    Tomas E, Stanojevic V, Habener JF.
    Horm Metab Res; 2010 Aug 07; 42(9):657-62. PubMed ID: 20645222
    [Abstract] [Full Text] [Related]

  • 30. Extrahypothalamic expression of the glucagon-like peptide-2 receptor is coupled to reduction of glutamate-induced cell death in cultured hippocampal cells.
    Lovshin JA, Huang Q, Seaberg R, Brubaker PL, Drucker DJ.
    Endocrinology; 2004 Jul 07; 145(7):3495-506. PubMed ID: 15059959
    [Abstract] [Full Text] [Related]

  • 31. Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.
    Runge S, Schimmer S, Oschmann J, Schiødt CB, Knudsen SM, Jeppesen CB, Madsen K, Lau J, Thøgersen H, Rudolph R.
    Biochemistry; 2007 May 15; 46(19):5830-40. PubMed ID: 17444618
    [Abstract] [Full Text] [Related]

  • 32. Characterization of [¹²⁵I]GLP-1(9-36), a novel radiolabeled analog of the major metabolite of glucagon-like peptide 1 to a receptor distinct from GLP1-R and function of the peptide in murine aorta.
    Kuc RE, Maguire JJ, Siew K, Patel S, Derksen DR, Margaret Jackson V, O'Shaughnessey KM, Davenport AP.
    Life Sci; 2014 May 02; 102(2):134-8. PubMed ID: 24641952
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Constructing glucagon like peptide-1 receptor fused with derivatives of GFP for visualizing protein-protein interaction in living cells.
    Bavec A.
    Mol Biol Rep; 2010 Jul 02; 37(6):2749-55. PubMed ID: 19757164
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa.
    Walsh NA, Yusta B, DaCambra MP, Anini Y, Drucker DJ, Brubaker PL.
    Endocrinology; 2003 Oct 02; 144(10):4385-92. PubMed ID: 12960094
    [Abstract] [Full Text] [Related]

  • 37. Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery.
    Koole C, Wootten D, Simms J, Miller LJ, Christopoulos A, Sexton PM.
    J Pharmacol Exp Ther; 2015 Apr 02; 353(1):52-63. PubMed ID: 25630467
    [Abstract] [Full Text] [Related]

  • 38. Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow.
    Jensen EP, Poulsen SS, Kissow H, Holstein-Rathlou NH, Deacon CF, Jensen BL, Holst JJ, Sorensen CM.
    Am J Physiol Renal Physiol; 2015 Apr 15; 308(8):F867-77. PubMed ID: 25656368
    [Abstract] [Full Text] [Related]

  • 39. Characterization of human and rat glucagon-like peptide-1 receptors in the neurointermediate lobe: lack of coupling to either stimulation or inhibition of adenylyl cyclase.
    Satoh F, Beak SA, Small CJ, Falzon M, Ghatei MA, Bloom SR, Smith DM.
    Endocrinology; 2000 Apr 15; 141(4):1301-9. PubMed ID: 10746632
    [Abstract] [Full Text] [Related]

  • 40. Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway.
    Gupta NA, Mells J, Dunham RM, Grakoui A, Handy J, Saxena NK, Anania FA.
    Hepatology; 2010 May 15; 51(5):1584-92. PubMed ID: 20225248
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.